Synthesis and pharmacological study of 5-aryl-6-methyl-4,5-dihydro-pyridazin-3 (2H) ones and related 5-aryl-6-methyl-pyridazin-3 (2H) ones

Pinna, G.A.; Curzu, M.M.; Barlocco, D.; Cignarella, G.; Cavalletti, E.; Germini, M.; Berger, K.

Il Farmaco; Edizione Scientifica 43(6): 539-549

1988


ISSN/ISBN: 0430-0920
PMID: 3208896
Document Number: 4674
New 5-aryl-6-methyl-4,5-dihydropyridazin-3(2H)ones (III) and related 5-aryl-6-methyl-pyridazin-3(2H)ones (IV) were synthesized in order to evaluate their pharmacological profile in comparison with that of the known class of antihypertensive and platelet aggregation inhibitors 5-methyl-6-aryl-4,5-dihydropyridazin 3(2H)ones (I). Though none of the tested derivatives was found to possess the antihypertensive potency of the reference compounds, some of them displayed significant antithrombotic and antiulcer properties. In particular, 5(p. acetylaminophenyl)-6-methyl-pyridazin-3-one (IV c) was found highly effective (ED50 = 1.2 mg/kg) in inhibiting indomethacin-induced ulcers.

Document emailed within 1 workday
Secure & encrypted payments

Synthesis and pharmacological study of 5-aryl-6-methyl-4,5-dihydro-pyridazin-3(2H)ones and related 5-aryl-6-methyl-pyridazin-3(2H)ones